Management of asymptomatic hypoglycemia with 40% oral dextrose gel in near term at-risk infants to reduce intensive care need and promote breastfeeding
- PMID:34627324
- PMCID: PMC8500822
- DOI: 10.1186/s13052-021-01149-7
Management of asymptomatic hypoglycemia with 40% oral dextrose gel in near term at-risk infants to reduce intensive care need and promote breastfeeding
Abstract
Background: Neonatal hypoglycemia is a common disorder especially in at-risk infants and it can be associated with poor long-term neurological outcomes. Several therapeutic interventions are suggested, from the implementation of breastfeeding to the glucose intravenous administration. Oral dextrose gel massaged into the infant's inner cheek is a recent treatment option of asymptomatic hypoglycemia, after which oral feeding is encouraged. This approach seems to reduce the admission of infants to neonatal intensive care unit (NICU) so favouring maternal bonding and breastfeeding success at discharge.
Methods: In our ward, we prospectively compared a group of near-term neonates, (Gr2, n = 308) at risk for hypoglycemia, treated with an innovative protocol based on the addition of 40% oral dextrose gel (Destrogel, Orsana®,Italy) administered by massaging gums and cheek with historical matching newborns (Gr1, n = 389) treated with a formerly used protocol, as control group. The primary outcome was occurrence of NICU admission and the requirement of intravenous glucose administration; while discharge with full breastfeeding was the secondary outcome.
Results: In Gr1, 39/389 (10%) infants presented with asymptomatic hypoglycemia, 19/39 were transferred to the NICU, and 14/39 required intravenous glucose treatment. In Gr2, among the 30/308 infants with asymptomatic hypoglycemia managed according to the new protocol, 3/30 were transferred to the NICU and received intravenous glucose infusion. The mean duration of hospitalization respectively was 6.43 (± 6.36) and 3.73 ± 1.53 days (p < 0.001). At discharge, 7.7% of the infants in Gr1 and 30% of the infants in Gr2 were exclusively breastfed (p = 0.02). Considering Gr1 vs Gr2, the number of patients that were transferred to NICU was 19 (48.7%) vs 3 (10%) (p = 0.001) and the number of infants that needed intravenous glucose infusion was 14 (35.9%) vs 3 (10%) (p = 0.01), respectively.
Conclusions: In our population of near term infants, the introduction of 40% oral dextrose gel to the protocol, helped in the safe management of asymptomatic hypoglycemia and, at the same time, implemented breastfeeding.
Keywords: 40% oral dextrose gel; At-risk newborns; Breastfeeding; Hypoglycemia; NICU admission; Neonatal intensive care unit.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
- Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial.Harding JE, Hegarty JE, Crowther CA, Edlin RP, Gamble GD, Alsweiler JM; hPOD Study Group.Harding JE, et al.PLoS Med. 2021 Jan 28;18(1):e1003411. doi: 10.1371/journal.pmed.1003411. eCollection 2021 Jan.PLoS Med. 2021.PMID:33507929Free PMC article.Clinical Trial.
- Oral Dextrose gel use in asymptomatic hypoglycemic newborns decreases NICU admissions and parenteral dextrose therapy: A retrospective study.Parappil H, Gaffari M, Ahmed J, Skaria S, Rijims M, Chandra P, Babu KTS.Parappil H, et al.J Neonatal Perinatal Med. 2023;16(1):111-117. doi: 10.3233/NPM-221170.J Neonatal Perinatal Med. 2023.PMID:36872799
- Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study).Hegarty JE, Harding JE, Gamble GD, Crowther CA, Edlin R, Alsweiler JM.Hegarty JE, et al.PLoS Med. 2016 Oct 25;13(10):e1002155. doi: 10.1371/journal.pmed.1002155. eCollection 2016 Oct.PLoS Med. 2016.PMID:27780197Free PMC article.Clinical Trial.
- Glucose Gel as a Treatment Strategy for Transient Neonatal Hypoglycemia.Newnam KM, Bunch M.Newnam KM, et al.Adv Neonatal Care. 2017 Dec;17(6):470-477. doi: 10.1097/ANC.0000000000000426.Adv Neonatal Care. 2017.PMID:28857766Review.
- Hypoglycemia in the newborn.Jain A, Aggarwal R, Jeevasanker M, Agarwal R, Deorari AK, Paul VK.Jain A, et al.Indian J Pediatr. 2008 Jan;75(1):63-7. doi: 10.1007/s12098-008-0009-6.Indian J Pediatr. 2008.PMID:18245938Review.
Cited by
- Neonatal hypoglycemia: lack of evidence for a safe management.Roeper M, Hoermann H, Kummer S, Meissner T.Roeper M, et al.Front Endocrinol (Lausanne). 2023 Jun 8;14:1179102. doi: 10.3389/fendo.2023.1179102. eCollection 2023.Front Endocrinol (Lausanne). 2023.PMID:37361517Free PMC article.Review.
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia.Devarapalli V, Niven M, Canonigo J, Spray B, Avulakunta I, Beavers J, Andrews J, Dumpa V.Devarapalli V, et al.J Perinatol. 2024 Nov;44(11):1640-1646. doi: 10.1038/s41372-024-02133-9. Epub 2024 Oct 3.J Perinatol. 2024.PMID:39363038
- New insights in pediatrics in 2021: choices in allergy and immunology, critical care, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, neurology, nutrition, palliative care, respiratory tract illnesses and telemedicine.Caffarelli C, Santamaria F, Piro E, Basilicata S, Delle Cave V, Cipullo M, Bernasconi S, Corsello G.Caffarelli C, et al.Ital J Pediatr. 2022 Nov 26;48(1):189. doi: 10.1186/s13052-022-01374-8.Ital J Pediatr. 2022.PMID:36435791Free PMC article.Review.
References
- Hay WW, Raju TNK, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155(05):612–617. doi: 10.1016/j.jpeds.2009.06.044. - DOI - PMC - PubMed
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical